Clinical outcomes following rhythm control for atrial fibrillation: is early better?

References

• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation [Internet] 2014;129:837–847. [cited 2020 Nov 7] Available from: /pmc/articles/PMC4151302/?report=abstract
   PubMed Web of Science ®Google Scholar
• Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J [Internet]. 2013;34:2746–2751. Available from: https://doi.org/10.1093/eurheartj/eht280.
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European. Eur Heart J [Internet] 2020; 2020 [cited 2020 Mar 10]; Available from: https://doi.org/10.1093/eurheartj/ehaa612.
   Google Scholar
• Lip GYH. The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol. 2017;14:627–628.
   PubMed Web of Science ®Google Scholar
• Yoon M, Yang PS, Jang E, et al. Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple ABC (Atrial Fibrillation Better Care) pathway for integrated care management: a nationwide cohort study. Thromb Haemost [Internet]. 2019 [cited 2020 Dec 7];19:1695–1703. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/s–0039–1693516
   Web of Science ®Google Scholar
• Ding WY, Lip GYH, Potpara TS. Atrial fibrillation: can it be as easy as CC to ABC? Eur J Clin Invest [Internet]. 2020 [cited 2020 Dec 7];50. Available from:https://onlinelibrary.wiley.com/doi/10.1111/eci.13413
   Google Scholar
• Bunch TJ, May HT, Bair TL, et al. Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes. Hear Rhythm [Internet]. 2013 [cited 2020 Nov 7];10:1257–1262. Available from: http://www.heartrhythmjournal.com/article/S1547527113005511/fulltext
   PubMed Web of Science ®Google Scholar
• De Caterina R, Ageno W, Agnelli G, et al. The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: section V-Special Situations [Internet]. Thromb. Haemost. Georg Thieme Verlag. 2019; [cited 2020 Dec 8]. p. 17–38. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/s–0038–1675816
   Google Scholar
• Lip GYH, Banerjee A, Boriani G, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest 2018;154:1121–1201.
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Calkins H, et al. AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the american college of cardiology/american heart association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons. Circulation [Internet]. 2019;140:e125–e151. 2019 [cited 2020 Mar 10]; Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000665
   PubMed Web of Science ®Google Scholar
• Potpara TS, Lip GYH, Blomstrom-Lundqvist C, et al. The 4S-AF scheme (stroke risk; symptoms; severity of burden; substrate): a novel approach to in-depth characterization (rather than classification) of atrial fibrillation. Thromb Haemost [Internet]. 2020 [cited 2020 Sep 9]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32838473.
   Web of Science ®Google Scholar
• Arbelo E, Aktaa S, Bollmann A, et al. Quality indicators for the care and outcomes of adults with atrial fibrillation. Europace [Internet]. 2020; Available from: https://doi.org/10.1093/europace/euaa253.
   Google Scholar
• Sankaranarayanan R, Kirkwood G, Visweswariah R, et al. How does chronic atrial fibrillation influence mortality in the modern treatment Era? Curr Cardiol Rev [Internet]. 2015 [cited 2020 Nov 7];11:190–198. Available from: /pmc/articles/PMC4558350/?report=abstract.
   PubMed Web of Science ®Google Scholar
• Zhang YY, Qiu C, Davis PJ. et al., Predictors of progression of recently diagnosed atrial fibrillation in REgistry on cardiac rhythm DisORDers assessing the control of atrial fibrillation (RecordAF)-United States cohort. Am J Cardiol [Internet]. Elsevier; 2013 [cited 2020 Nov 7]. p. 79–84. Available from: www.ajconline.orghttp://dx
   PubMed Web of Science ®Google Scholar
• Wyse DG, Waldo AL, DiMarco JP, et al. A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation. N Engl J Med [Internet]. 2002;347:1825–1833. [cited 2020 Nov 8]; Available from: www.nejm.org
   PubMed Web of Science ®Google Scholar
• Epstein AE. Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation [Internet]. [cited 2020 Nov 8];109:1509–1513. Available from. 2004: https://www.ahajournals.org/doi/10.1161/01.CIR.0000121736.16643.11
   PubMed Web of Science ®Google Scholar
• Purmah Y, Proietti M, Laroche C, et al. Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation. Europace [Internet]. 2018;20:243–252. Available from: https://doi.org/10.1093/europace/euw421.
   PubMed Web of Science ®Google Scholar
• Kelly JP, DeVore AD, Wu JJ, et al. Rhythm control versus rate control in patients with atrial fibrillation and heart failure with preserved ejection fraction: insights from get with the guidelines-heart failure. J Am Heart Assoc [Internet]. 2019 [cited 2020 Nov 11];8:e011560. Available from: https://www.ahajournals.org/doi/10.1161/JAHA.118.011560
   PubMed Web of Science ®Google Scholar
• Chen S, Dong Y, Fan J, et al. Rate vs. rhythm control in patients with atrial fibrillation - An updated meta-analysis of 10 randomized controlled trials. Int J Cardiol [Internet]. 2011 [cited 2020 Dec 10];153:96–98. Available from: http://www.internationaljournalofcardiology.com/article/S0167527311017207/fulltext
   PubMed Web of Science ®Google Scholar
• Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med [Internet] [cited 2020 Dec 10];347:1834–1840. Available from 2002;: www.nejm.org
   PubMed Web of Science ®Google Scholar
• Noheria A, Shrader P, Piccini JP, et al. Rhythm Control Versus Rate Control and Clinical Outcomes in Patients with Atrial Fibrillation: results from the ORBIT-AF Registry. JACC Clin Electrophysiol. 2016;2:221–229.
   PubMedGoogle Scholar
• Mujović N, Marinković M, Lenarczyk R, et al. Catheter ablation of atrial fibrillation: an overview for clinicians. Adv Ther. 2017;34:1897–1917.
   PubMed Web of Science ®Google Scholar
• Gupta A, Perera T, Ganesan A, et al. Complications of catheter ablation of atrial fibrillation: a systematic review. Circ Arrhythm Electrophysiol [Internet]. 2013 [cited 2020 Dec 9];6:1082–1088. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24243785
   PubMed Web of Science ®Google Scholar
• Hussein A, Das M, Riva S, et al. Use of ablation index-guided ablation results in high rates of durable pulmonary vein isolation and freedom from arrhythmia in persistent atrial fibrillation patients. Circ Arrhythm Electrophysiol [Internet]. 2018 [cited 2020 Dec 9];11:e006576. Available from: https://www.ahajournals.org/doi/10.1161/CIRCEP.118.006576
   PubMed Web of Science ®Google Scholar
• Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA Randomized Clinical Trial. JAMA. 2019;321:1261–1274. Available from https://doi.org/10.1001/jama.2019.0693.
   PubMed Web of Science ®Google Scholar
• Noseworthy PA, Gersh BJ, Kent DM, et al. Atrial fibrillation ablation in practice: assessing CABANA generalizability. Eur Heart J [Internet]. 2019;40:1257–1264. Available from https://doi.org/10.1093/eurheartj/ehz085.
   PubMed Web of Science ®Google Scholar
• Saglietto A, De Ponti R, Di Biase L, et al. Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: a meta‐analysis. J Cardiovasc Electrophysiol [Internet]. 2020 [cited 2020 Nov 11];31:1040–1047. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/jce.14429
   PubMed Web of Science ®Google Scholar
• Guo J, Nayak HM, Besser SA, et al. Impact of Atrial Fibrillation Ablation on Recurrent Hospitalization: a Nationwide Cohort Study. JACC Clin Electrophysiol. 2019;5:330–339.
   PubMedGoogle Scholar
• Bertaglia E, Senatore G, De Michieli L, et al. Twelve-year follow-up of catheter ablation for atrial fibrillation: a prospective, multicenter, randomized study. Hear Rhythm [Internet]. 2017 [cited 2020 Nov 8];14:486–492. Available from: http://www.heartrhythmjournal.com/article/S1547527116312140/fulltext
   PubMed Web of Science ®Google Scholar
• Kim M, Yu HT, Kim J, et al. Atrial fibrillation and the risk of ischaemic strokes or intracranial haemorrhages: comparisons of the catheter ablation, medical therapy, and non-atrial fibrillation population. Eur Eur pacing, arrhythmias, Card Electrophysiol J Work groups Card pacing, arrhythmias, Card Cell Electrophysiol Eur Soc Cardiol 2020.
   Google Scholar
• Ding WY, Gupta D. Catheter ablation: the “Pym Particles” of atrial fibrillation? Europace [Internet]. 2020; Available from: https://doi.org/10.1093/europace/euaa299.
   Google Scholar
• Kim D, Yang P-S, Sung J-H, et al. Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study. Eur Heart J [Internet]. 2020. Available from https://doi.org/10.1093/eurheartj/ehaa726.
   Google Scholar
• Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med [Internet]. 2018;378:417–427. [cited 2020 Nov 8] Available from: https://www.nejm.org/doi/10.1056/NEJMoa1707855.
   PubMed Web of Science ®Google Scholar
• Noseworthy PA, Van Houten HK, Gersh BJ, et al. Generalizability of the CASTLE-AF trial: catheter ablation for patients with atrial fibrillation and heart failure in routine practice. Hear Rhythm [Internet]. 2020 [cited 2020 Aug 22];17:1057–1065. Available from: https://pubmed.ncbi.nlm.nih.gov/32145348
   PubMed Web of Science ®Google Scholar
• Alturki A, Proietti R, Dawas A. et al., Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials [Internet]. BMC Cardiovasc Disord. BioMed Central Ltd.; 2019 [cited 2020 Nov 14]. p. 18. Available from: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-019-0998–2
   PubMedGoogle Scholar
• Chen S, Pürerfellner H, Meyer C, et al. Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data. Eur Heart J [Internet]. 2020;41:2863–2873. Available from https://doi.org/10.1093/eurheartj/ehz443.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Calkins H. Catheter ablation in patients with persistent atrial fibrillation. Eur Heart J [Internet]. 2017;38:20–26. Available from https://doi.org/10.1093/eurheartj/ehw260.
   PubMedGoogle Scholar
• Anselmino M, Matta M, D’Ascenzo F, et al. Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis [Internet]. Circ Arrhythmia Electrophysiol Lippincott Williams and Wilkins; 2014 [cited 2020 Dec 10]. p. 1011–1018. Available from. https://www.ahajournals.org/doi/10.1161/CIRCEP.114.001938
   PubMedGoogle Scholar
• Gaita F, Scaglione M, Battaglia A, et al. Very long-term outcome following transcatheter ablation of atrial fibrillation. Are results maintained after 10 years of follow up? Europace [Internet]. 2018;20:443–450. Available from: https://doi.org/10.1093/europace/eux008
   PubMed Web of Science ®Google Scholar
• Balla C, Cappato R. Atrial fibrillation ablation in heart failure. Eur Hear J Suppl [Internet]. 2020 [cited 2020 Nov 13];22:E50–E53. Available from./pmc/articles/PMC7270911/?report=abstract
   PubMed Web of Science ®Google Scholar
• Padfield GJ, Steinberg C, Swampillai J, et al. Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation. Hear Rhythm [Internet]. 2017 [cited 2020 Dec 10];14:801–807. Available from: http://www.heartrhythmjournal.com/article/S1547527117301492/fulltext
   PubMed Web of Science ®Google Scholar
• Nattel S, Guasch E, Savelieva I, et al. Early management of atrial fibrillation to prevent cardiovascular complications. Eur Heart J [Internet]. 2014;35:1448–1456. Available from https://doi.org/10.1093/eurheartj/ehu028.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med [Internet]. [cited 2020 Nov 14];383:1305–1316. Available from. 2020; https://www.nejm.org/doi/10.1056/NEJMoa2019422
   PubMed Web of Science ®Google Scholar
• Piccini JP, Allred J, Bunch TJ, et al. Rationale, considerations, and goals for atrial fibrillation centers of excellence: a Heart Rhythm Society perspective. Hear Rhythm [Internet]. 2020 [cited 2020 Nov 15];17:1804–1832. Available from: https://doi.org/10.1016/j.hrthm.2020.04.033.
   PubMed Web of Science ®Google Scholar
• Bunch TJ, Steinberg BA. Revisiting Rate versus Rhythm Control in Atrial Fibrillation—timing Matters. N Engl J Med [Internet]. 2020;383:1383–1384. Available from https://doi.org/10.1056/NEJMe2027180.
   PubMed Web of Science ®Google Scholar
• Cosedis Nielsen J, Johannessen A, Raatikainen P, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med [Internet]. 2012;367:1587–1595. Available from: https://doi.org/10.1056/NEJMoa1113566
   PubMed Web of Science ®Google Scholar
• Wazni OM, Dandamudi G, Sood N, et al. Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation. N Engl J Med [Internet] 2020. [cited 2020 Dec 10]; Available from https://www.nejm.org/doi/full/10.1056/NEJMoa2029554.
   PubMed Web of Science ®Google Scholar
• Andrade JG, Wells GA, Deyell MW, et al. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. N Engl J Med [Internet] 2020. [cited 2020 Dec 10]; Available from https://www.nejm.org/doi/full/10.1056/NEJMoa2029980.
   PubMed Web of Science ®Google Scholar
• Hermida JS, Chen J, Meyer C, et al. Cryoballoon catheter ablation versus antiarrhythmic drugs as a first-line therapy for patients with paroxysmal atrial fibrillation: rationale and design of the international Cryo-FIRST study . Am Heart J. 2020;222:64–72. Available from: http://www.sciencedirect.com/science/article/pii/S0002870319303461
   PubMed Web of Science ®Google Scholar
• Vedran V, NIkola P, Gian-Battista C, et al. abstract 13915: cryoballoon catheter ablation versus antiarrhythmic drug as a first-line therapy for patients with paroxysmal atrial fibrillation: results of the cryo-first study. Circulation [Internet]. 2020;142:A13915–A13915. Available from https://doi.org/10.1161/circ.142.suppl_3.13915.
   Web of Science ®Google Scholar
• Chierchia GB, Pavlovic N, Velagic V, et al. Quality of life measured in first-line therapy during the Cryo-FIRST study: a comparison between cryoballoon catheter ablation versus antiarrhythmic drug therapy. Eur Heart J [Internet]. 2020;41. Available from https://doi.org/10.1093/ehjci/ehaa946.0436.
   Web of Science ®Google Scholar
• Kuck K-H, Lebedev DS, Mikhaylov EN, et al. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). EP Eur [Internet]. 2020; Available from: https://doi.org/10.1093/europace/euaa298.
   Google Scholar
• Sawhney V, Schilling RJ, Providencia R, et al. Cryoablation for persistent and longstanding persistent atrial fibrillation: results from a multicentre European registry. Europace [Internet]. 2020 [cited 2020 Nov 9];22:375–381. Available from: https://academic.oup.com/europace/article/22/3/375/5662413
   PubMed Web of Science ®Google Scholar
• Hussein AA, Saliba WI, Barakat A, et al. Radiofrequency ablation of persistent atrial fibrillation: diagnosis-to-ablation time, markers of pathways of atrial remodeling, and outcomes. Circ Arrhythmia Electrophysiol [Internet]. 2016 [cited 2020 Nov 15];9. Available from: https://www.ahajournals.org/doi/10.1161/CIRCEP.115.003669
   Google Scholar
• Jones DG, Haldar SK, Donovan J, et al. Biomarkers in Persistent AF and Heart Failure: impact of Catheter Ablation Compared with Rate Control. Pacing Clin Electrophysiol [Internet]. 2016 [cited 2020 Nov 15];39:926–934. Available from: http://doi.wiley.com/10.1111/pace.12919
   PubMed Web of Science ®Google Scholar
• Aronsson M, Walfridsson H, Janzon M, et al. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy. Europace [Internet]. 2015;17:48–55. Available from: https://doi.org/10.1093/europace/euu188.
   PubMed Web of Science ®Google Scholar
• Mörtsell D, Arbelo E, Dagres N, et al. Cryoballoon vs. radiofrequency ablation for atrial fibrillation: a study of outcome and safety based on the ESC-EHRA atrial fibrillation ablation long-term registry and the Swedish catheter ablation registry. Europace [Internet]. 2019;21:581–589. Available from: https://doi.org/10.1093/europace/euy239.
   PubMed Web of Science ®Google Scholar
• Kim YG, Choi J-I, Boo KY, et al. Clinical and echocardiographic risk factors predict late recurrence after radiofrequency catheter ablation of atrial fibrillation. Sci Rep [Internet]. 2019;9:6890. Available from: https://doi.org/10.1038/s41598-019-43283-7.
   PubMed Web of Science ®Google Scholar
• Dretzke J, Chuchu N, Agarwal R, et al. Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models. Europace [Internet]. 2020;22:748–760. Available from: https://doi.org/10.1093/europace/euaa041.
   PubMed Web of Science ®Google Scholar
• Trines SA, Stabile G, Arbelo E, et al. Influence of risk factors in the ESC-EHRA EORP atrial fibrillation ablation long-term registry. PACE - Pacing Clin Electrophysiol [Internet]. 2019 [cited 2020 Dec 15];42:1365–1373. Available from: https://pubmed.ncbi.nlm.nih.gov/31355938
   PubMed Web of Science ®Google Scholar
• Dennis HL, Stanley N, Jonathan MK, et al. Modifiable Risk Factors and Atrial Fibrillation. Circulation [Internet]. 2017;136:583–596. Available from: https://doi.org/10.1161/CIRCULATIONAHA.116.023163
   Google Scholar
• Nedios S, Kosiuk J, Koutalas E, et al. Comparison of left atrial dimensions in CT and echocardiography as predictors of long-term success after catheter ablation of atrial fibrillation. J Interv Card Electrophysiol [Internet]. 2015 [cited 2020 Dec 15];43:237–244. Available from: https://link.springer.com/article/10.1007/s10840-015-0010–8
   PubMed Web of Science ®Google Scholar
• D’Ascenzo F, Corleto A, Biondi-Zoccai G, et al. Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis. Int J Cardiol [Internet]. 2013 [cited 2020 Dec 15];167:1984–1989. Available from: http://www.internationaljournalofcardiology.com/article/S0167527312006195/fulltext.
   PubMed Web of Science ®Google Scholar
• Arbelo E, Brugada J, Blomström-Lundqvist C, et al. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J. 2017;38:1303–1316.
   PubMed Web of Science ®Google Scholar
• Haeusler KG, Kirchhof P, Endres M. Left atrial catheter ablation and ischemic stroke. Stroke [Internet]. [cited 2020 Nov 14];43:265–270. Available from. 2012;:. https://www.ahajournals.org/doi/10.1161/STROKEAHA.111.627067
   PubMed Web of Science ®Google Scholar
• Willems S, Meyer C, De Bono J, et al. Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation. Eur Heart J [Internet]. 2019;40:3793–3799c. Available from: https://doi.org/10.1093/eurheartj/ehz782.
   PubMed Web of Science ®Google Scholar
• Dinshaw L, Schäffer B, Ö A, et al. Long‐term efficacy and safety of radiofrequency catheter ablation of atrial fibrillation in patients with cardiac implantable electronic devices and transvenous leads. J Cardiovasc Electrophysiol [Internet]. 2019 [cited 2020 Nov 14];30:679–687. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/jce.13890
   PubMed Web of Science ®Google Scholar
• Tilz RR, Heeger CH, Wick A, et al. Ten-Year Clinical Outcome after Circumferential Pulmonary Vein Isolation Utilizing the Hamburg Approach in Patients with Symptomatic Drug-Refractory Paroxysmal Atrial Fibrillation. Circ Arrhythmia Electrophysiol [Internet]. 2018 [cited 2020 Nov 14];11. Available from: https://www.ahajournals.org/doi/10.1161/CIRCEP.117.005250
   Google Scholar
• Buchta P, Sierpiński R, Myrda K, et al. New hope for patients and challenges for the multidisciplinary arrhythmia team: a hybrid convergent approach for atrial fibrillation treatment. Kardiol Pol.;2020. doi: 10.33963/KP.15640
   Web of Science ®Google Scholar
• Berger WR, Meulendijks ER, Limpens J, et al. Persistent atrial fibrillation: a systematic review and meta-analysis of invasive strategies. Int J Cardiol [Internet]. 2019 [cited 2020 Nov 14];278:137–143. Available from: https://doi.org/10.1016/j.ijcard.2018.11.127.
   PubMed Web of Science ®Google Scholar
• Swaans MJ, Post MC, Rensing BJWM, et al. Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study. J Am Heart Assoc. 2012; 1: doi:10.1161/JAHA.112.002212
   PubMed Web of Science ®Google Scholar
• Phillips KP, Romanov A, Artemenko S, et al. Combining left atrial appendage closure and catheter ablation for atrial fibrillation: 2-year outcomes from a multinational registry. Europace 2020;22:225–231.
   PubMed Web of Science ®Google Scholar
• Kotalczyk A, Mazurek M, Kalarus Z, et al. Stroke prevention strategies in high-risk patients with atrial fibrillation. Nat Rev Cardiol [Internet]. 2020; Available from: https://doi.org/10.1038/s41569-020-00459-3.
   PubMed Web of Science ®Google Scholar
• Gorenek (Chair) B, Halvorsen S, Kudaiberdieva G, et al. Atrial fibrillation in acute heart failure: a position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology. European Heart Journal: Acute Cardiovascular Care. 2020 [cited 2020 Nov 11];9:348–357. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31976747
   PubMed Web of Science ®Google Scholar
• Brandes A, Crijns HJGM, Rienstra M, et al. Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure. Europace [Internet]. 2020;22:1149–1161. Available from: https://doi.org/10.1093/europace/euaa057.
   PubMed Web of Science ®Google Scholar
• Cho Y, Oh I-Y, Park JJ, et al. Impact of successful restoration of sinus rhythm in patients with atrial fibrillation and acute heart failure: results from the Korean Acute Heart Failure registry. Cardiology Journal. 2020. Available from https://doi.org/10.5603/CJ.a2020.0103.
   Google Scholar
• Airaksinen KEJ. Early versus delayed cardioversion: why should we wait? [Internet]. Expert Review of Cardiovascular Therapy. Taylor and Francis Ltd; 2020 [cited 2020 Nov 13]. p. 149–154. Available from: https://www.tandfonline.com/doi/abs/10.1080/14779072.20201736563
   PubMed Web of Science ®Google Scholar
• Gorenek B, Pelliccia A, Benjamin EJ, et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Eur J Prev Cardiol [Internet]. 2017 [cited 2020 Nov 11];24:4–40. Available from: http://journals.sagepub.com/doi/10.1177/2047487316676037
   PubMed Web of Science ®Google Scholar
• Javed S, Gupta D, Lip GYH. Obesity and atrial fibrillation: making inroads through fat. Eur Hear J - Cardiovasc Pharmacother [Internet]. 2020; Available from: https://doi.org/10.1093/ehjcvp/pvaa013.
   Google Scholar
• Lip GYH, Merino JL, Banach M, et al. Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) randomized trial. J Arrhythmia. 2020;36:430–438. [cited 2020 Nov 13. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/joa3.12341
   PubMed Web of Science ®Google Scholar
• Middeldorp ME, Pathak RK, Meredith M, et al. PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study. 2018. EP Europace. 20:1929–1935. Available from: https://doi.org/10.1093/europace/euy117.
   PubMed Web of Science ®Google Scholar
• Rienstra M, Hobbelt AH, Alings M, et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. Eur Heart J [Internet]. 2018;39(32):2987–2996. Available from.https://doi.org/10.1093/eurheartj/ehx739
   PubMed Web of Science ®Google Scholar
• Bhardwaj R, Koruth JS. Novel ablation approaches for challenging atrial fibrillation cases (mapping, irrigation, and catheters). Cardiology Clinics. 2019;37:207–219. Available from: http://www.sciencedirect.com/science/article/pii/S0733865119300128 2
   PubMed Web of Science ®Google Scholar
• Rottner L, Bellmann B, Lin T, et al. Catheter ablation of atrial fibrillation: state of the art and future perspectives. Cardiolo Therapy. 2020; 9:45–58. Available from. https://doi.org/10.1007/s40119-019-00158-2.
   PubMed Web of Science ®Google Scholar
• Aj G, Jean C, Marc D, et al. Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring. Circulation [Internet]. 2019;140:1779–1788. Available from https://doi.org/10.1161/CIRCULATIONAHA.119.042622.
   PubMed Web of Science ®Google Scholar
• Kuck K-H, Brugada J, Fürnkranz A, et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med [Internet]. 2016;374(23):2235–2245. Available from.
   PubMed Web of Science ®Google Scholar
• Manolis AS, Ablation of atrial fibrillation: single-shot techniques poised to dominate rhythm control strategies/the future is here [Internet]. Journal of Thoracic Disease. AME Publishing Company; 2017 [cited 2020 Nov 15]. p. E313–E321. Available from ;9(3);./pmc/articles/PMC5394036/?report=abstract
   PubMed Web of Science ®Google Scholar
• Bellmann B, Lin T, Ruppersberg P, et al. Identification of active atrial fibrillation sources and their discrimination from passive rotors using electrographical flow mapping. Clinical Research in Cardiology. 2016;374(11):1021–1032. Available from. .
   Google Scholar
• Bellmann B, Zettwitz M, Lin T, et al. Velocity characteristics of atrial fibrillation sources determined by electrographic flow mapping before and after catheter ablation. International Journal of Cardiology [cited 2020 Nov 15];383:56–60. Available from 2020; http://www.internationaljournalofcardiology.com/article/S0167527318368992/fulltext
   Google Scholar
• Koruth JS, Kuroki K, Kawamura I, et al. Focal pulsed field ablation for pulmonary vein isolation and linear atrial lesions: a preclinical assessment of safety and durability. Circ Arrhythmia Electrophysiol [Internet]. 2020 [cited 2020 Nov 13];13:514–528. Available from:https://www.ahajournals.org/doi/10.1161/CIRCEP.120.008716
   Web of Science ®Google Scholar
• Bradley CJ, Haines DE, Pulsed field ablation for pulmonary vein isolation in the treatment of atrial fibrillation. Journal of Cardiovascular Electrophysiology. [cited 2020 Nov 13];31:2136–2147. Available from. 2020;(8):. https://onlinelibrary.wiley.com/doi/abs/10.1111/jce.14414
   PubMed Web of Science ®Google Scholar
• Reddy VY, Neuzil P, Koruth JS, et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol.. 2019;74(3):315–326.
   PubMed Web of Science ®Google Scholar
• Perez MV, Mahaffey KW, Hedlin H, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med [Internet]. [cited 2020 Apr 28];381:1909–1917. Available from. 2019;(20): http://www.nejm.org/doi/10.1056/NEJMoa1901183.
   PubMed Web of Science ®Google Scholar
• Turakhia MP, Desai M, Hedlin H, et al. Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: the apple heart study. Am Heart J. 2019;207:66–75.
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang H, Zhang H, et al. Mobile photoplethysmographic technology to detect atrial fibrillation. J Ame CollegeCardiol. 2019;74(19):2365–2375.
   Web of Science ®Google Scholar
• Giada F, Gulizia M, Francese M, et al. Recurrent Unexplained Palpitations (RUP) study comparison of implantable loop recorder versus conventional diagnostic strategy. J Am Coll Cardiol. 2007;49:1951–1956.
   PubMed Web of Science ®Google Scholar
• Sanna T, Diener H-C, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med [Internet]. [cited 2020 Aug 23];370:2478–2486. Available from. 2014;(26) http://www.nejm.org/doi/10.1056/NEJMoa1313600.
   PubMed Web of Science ®Google Scholar
• Guo Y, Lane DA, Wang L, et al. Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: the mAFA (mAF‐App) II randomised trial. Int J Clin Pract [Internet]. 2019 [cited 2020 May 16];73. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/ijcp.13352
   Web of Science ®Google Scholar
• Andrade JG, Deyell MW, Verma A, et al. Association of atrial fibrillation episode duration with arrhythmia recurrence following ablation: a secondary analysis of a randomized clinical trial. 2020. JAMA Network Open. ;3 e208748–e208748. Available from. (7):. https://doi.org/10.1001/jamanetworkopen.2020.8748.
   PubMed Web of Science ®Google Scholar
• Kim M, Hong M, Kim JY, et al. Clinical relationship between anemia and atrial fibrillation recurrence after catheter ablation without genetic background. IJC Hear Vasc. 2020;27:100507.
   PubMed Web of Science ®Google Scholar
• Yanagisawa S, Inden Y, Kato H, et al. Impaired renal function is associated with recurrence after cryoballoon catheter ablation for paroxysmal atrial fibrillation: a potential effect of non-pulmonary vein foci. J Cardiol [Internet]. 2017 [cited 2020 Sep 28;69:3–10. Available from: http://dx.doi.org/10.1016/j.jjcc.2016.08.002.
   PubMed Web of Science ®Google Scholar
• Li M, Liu T, Luo D, et al. Systematic review and meta-analysis of chronic kidney disease as predictor of atrial fibrillation recurrence following catheter ablation. Cardiol J [Internet]. 2014 cited 2020 Sep 28;21:89–95. Available from: www.cardiologyjournal.org
   PubMed Web of Science ®Google Scholar
• Deng H, Shantsila A, Xue Y, et al. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: the Guangzhou atrial fibrillation ablation registry. Arch Cardiovasc Dis.. 2019;112:420–429.
   PubMed Web of Science ®Google Scholar
• Guhl E, Althouse AD, Pusateri AM, et al. The Atrial Fibrillation Health Literacy Information Technology Trial: pilot Trial of a Mobile Health App for Atrial Fibrillation, JMIR cardio [Internet]. 2020 cited 2020 Nov 14;4:e17162. Available from, ; . ., http://www.ncbi.nlm.nih.gov/pubmed/32886070,1
   PubMedGoogle Scholar
• Chao T-F, Liao J-N, Tuan T-C, et al. Incident co-morbidities in patients with atrial fibrillation initially with a cha2ds2-vasc score of 0 (males) or 1 (females): implications for reassessment of stroke risk in initially ‘low-risk’ patients, Thrombosis and Haemostasis. 2019 cited 2020 Dec 8;119:1162–1170. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-1683933
   PubMed Web of Science ®Google Scholar
• Kotalczyk A, Kalarus Z, Wright DJ. et al., cardiac electronic devices: future directions and challenges. Medical Devices: Evidence and Research]. Dove Medical Press Ltd; 2020 cited 2020 Oct 25. p. 325–338. Available from: /pmc/articles/PMC7526741/?report=abstract 13
   Web of Science ®Google Scholar